Cronos Group Inc. Stock

Equities

CRON

CA22717L1013

Pharmaceuticals

Market Closed - Toronto S.E. 16:00:00 2024-07-12 EDT 5-day change 1st Jan Change
3.29 CAD +0.92% Intraday chart for Cronos Group Inc. +8.22% +18.77%
Sales 2024 * 141M 104M Sales 2025 * 173M 127M Capitalization 1.26B 922M
Net income 2024 * -29M -21.26M Net income 2025 * -3M -2.2M EV / Sales 2024 * 1.45 x
Net cash position 2024 * 1.05B 771M Net cash position 2025 * 938M 687M EV / Sales 2025 * 1.85 x
P/E ratio 2024 *
-52.4 x
P/E ratio 2025 *
-159 x
Employees 356
Yield 2024 *
-
Yield 2025 *
-
Free-Float 52.41%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.92%
1 week+8.22%
Current month+3.13%
1 month-2.95%
3 months-4.64%
6 months+22.30%
Current year+18.77%
More quotes
1 week
3.02
Extreme 3.02
3.31
1 month
3.02
Extreme 3.02
3.31
Current year
2.56
Extreme 2.56
4.28
1 year
2.20
Extreme 2.2
4.28
3 years
2.15
Extreme 2.145
9.71
5 years
2.15
Extreme 2.145
20.72
10 years
0.14
Extreme 0.14
32.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 37 15-11-05
Director of Finance/CFO 41 22-11-13
Chief Tech/Sci/R&D Officer 41 -
Members of the board TitleAgeSince
Director/Board Member 57 18-01-31
Director/Board Member 52 16-07-11
Chief Executive Officer 37 15-11-05
More insiders
Date Price Change Volume
24-07-12 3.29 +0.92% 73,821
24-07-11 3.26 +3.82% 109,586
24-07-10 3.14 +2.28% 71,773
24-07-09 3.07 -0.32% 60,859
24-07-08 3.08 +1.32% 77,379

Delayed Quote Toronto S.E., July 12, 2024 at 04:00 pm

More quotes
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Lord Jones are hemp-derived cannabidiol (CBD) brand. Its Lord Jones Hash Fusions is a line-up of premium ice water hash infused pre-rolls. Its PEACE NATURALS offers Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
3.29 CAD
Average target price
3.611 CAD
Spread / Average Target
+9.77%
Consensus